[1]
Pozo Sanhueza, P., Mondaca Muñoz, J.P., Diaz Aguirre, P.A. and Escalona Arranz, J.C. 2026. Applications and limitations of CRISPR-Cas9 in breast cancer therapy: A structured evidence review (2018–2026). Orange Journal. 8, 14 (Oct. 2026), 36–51. DOI:https://doi.org/10.46502/issn.2710-995X/2026.14.04.